Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
DiabetesFoot UlcerOsteomyelitis
Interventions
OTHER

1 cohort, standard care, observational

This is one cohort standard care observational study. 40 diabetic patients admitted to Parkland hospital with a foot infection. We will enroll a representative cross section of subjects with diabetic foot infection. Patient will be consented and will receive therapy based on standard protocols. Currently patients with suspected osteomyelitis have bone biopsies to identify bacterial pathogens and verify MRI diagnosis. Repeat bone biopsies are performed at the end of therapy to verify that osteomyelitis has been successfully treated. Serum to measure procalcitonin will be obtained at baseline, week 3 and week 6. Tissue samples will be obtained at Baseline, Week 3 and Week 6 for tissue culture.

Trial Locations (1)

75390-9132

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02165579 - Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis | Biotech Hunter | Biotech Hunter